Name
Linus Medical OÜ
Registry code
11548994
VAT number
EE101263526
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
24.10.2008 (16)
Financial year
01.01-31.12
Capital
6 391.00 €
Activity
55103 - Guest-houses 46462 - Wholesale of medical appliances and surgical and orthopaedic instruments and devices 47741 - Retail sale of medical and orthopaedic goods in specialised stores
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Osaühing Ranniku Invest 11314931 | 100% - 6 391.00 EUR | - | - | Founder |
| Lembit Allikmets 24.12.1970 (53) | - | Board member | Indirect ownership |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Linus Glükomed OÜ 11639840 | 100% - 2 556.00 EUR | - | - | |
| Peenjoogivabrik Nudist OÜ 12113169 | 2% - 200.00 EUR | - | - | |
| MTÜ Linus Medical Heategevusfond 80431286 | - | - | - | Founder (without contribution) |
| 2019 30.10.2020 | 2020 02.12.2021 | 2021 26.07.2022 | 2022 21.12.2023 | |
|---|---|---|---|---|
| Total Revenue | 9 139 246 € | 10 477 306 € | 10 939 876 € | 11 992 134 € |
| Net profit (loss) for the period | 422 411 € | 707 201 € | 785 042 € | 765 560 € |
| Profit Margin | 5% | 7% | 7% | 6% |
| Current Assets | 2 260 604 € | 2 781 807 € | 2 720 137 € | 3 256 678 € |
| Fixed Assets | 1 218 220 € | 1 622 440 € | 1 947 188 € | 2 518 359 € |
| Total Assets | 3 478 824 € | 4 404 247 € | 4 667 325 € | 5 775 037 € |
| Current Liabilities | 2 000 705 € | 2 498 441 € | 2 171 056 € | 2 640 136 € |
| Non Current Liabilities | 109 014 € | 0 € | 0 € | 0 € |
| Total Liabilities | 2 109 719 € | - | - | - |
| Share Capital | - | - | - | - |
| Equity | 1 369 105 € | 1 905 806 € | 2 496 269 € | 3 134 901 € |
| Employees | 30 | 29 | 39 | 33 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 5 124 856.51 € | 106 091.54 € | 74 454.65 € | 12 |
| 2023 Q4 | 4 099 373.98 € | 102 050.18 € | 72 188.53 € | 12 |
| 2023 Q3 | 3 670 097.84 € | 107 808.99 € | 71 840.57 € | 14 |
| 2023 Q2 | 3 272 116.19 € | 70 877.82 € | 61 242.38 € | 14 |
| 2023 Q1 | 3 641 866.86 € | 111 144.74 € | 84 691.55 € | 14 |
| 2022 Q4 | 4 430 178.34 € | 102 736.01 € | 70 589.34 € | 15 |
| 2022 Q3 | 5 150 197.56 € | 94 051.53 € | 75 081.44 € | 15 |
| 2022 Q2 | 4 548 419.99 € | 87 639.94 € | 73 863.69 € | 15 |
| 2022 Q1 | 4 290 988.07 € | 107 355.91 € | 62 678.69 € | 14 |
| 2021 Q4 | 4 346 204.15 € | 102 239.84 € | 54 587.33 € | 13 |
| 2021 Q3 | 4 031 174.79 € | 85 925.25 € | 52 719.23 € | 12 |
| 2021 Q2 | 4 229 841.77 € | 84 328.53 € | 60 335.48 € | 12 |
| 2021 Q1 | 4 274 177.2 € | 83 160.53 € | 55 705.89 € | 12 |
| 2020 Q4 | 4 655 542.36 € | 99 610.01 € | 47 408.82 € | 12 |
| 2020 Q3 | 3 852 129.34 € | 83 596.21 € | 50 067.15 € | 11 |
| 2020 Q2 | 4 207 629.79 € | 84 597.44 € | 49 244.24 € | 11 |
| 2020 Q1 | 3 815 544.95 € | 94 238.39 € | 55 350.83 € | 11 |
